Cet anticorps anti-NFKBIA Monoclonal Souris (Clone 6A055) (ABIN155061) détecte spécifiquement NFKBIA dans WB et IP.
L’anticorps est réactif avec des échantillons de Humain.
KD Validated
NFKBIA
Reactivité: Humain
WB, IF (p), FACS
Hôte: Lapin
Monoclonal
25GB4040
unconjugated
Recombinant Antibody
Indications d'application
Western Blot: 0.5-4 μg/mL. Immunoprecipitation: 1-4 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C/-80 °C
Stockage commentaire
Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -20 °C to-70 °C. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Date de péremption
12 months
Antigène
NFKBIA
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, alpha (NFKBIA))
Autre désignation
NFKBIA / IKBA
Sujet
NF-κB is silenced in the cytoplasm by an inhibitory protein, IκB. IκB proteins are phosphorylated by IκB kinase complex consisting of at least three proteins, IKK1/α, IKK2/β, and IKK3/γ. External stimuli such TNF-α or other cytokines results in phosphorylation and degradation of IκB releasing NF-κB dimers. NF-κB dimer subsequently translocates to the nucleus and activates target genes. Six members of IκB family members have been identified. One of the first gene induced following NF-κB activation is IκBα.Synonyms: I kappa B-alpha, I-kappa-B-alpha, IkB-alpha, IkappaBalpha, MAD3, Major histocompatibility complex enhancer-binding protein MAD3, NF-kappa-B inhibitor alpha, NFKBI